Initial non-compliance with antihypertensive monotherapy is followed by complete discontinuation of antihypertensive therapy

Pharmacoepidemiology and Drug Safety

Volumn 15, Issue 8, 2006, Pages 587-593

  Van Wijk, Boris L G ^a   Klungel, Olaf H ^a   Heerdink, Eibert R ^a   de Boer, Anthonius ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Antihypertensives; Discontinuation; Hypertension; Non compliance

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTIASTHMATIC AGENT; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; DATA BASE; DRUG WITHDRAWAL; FEMALE; HIGH RISK POPULATION; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; HYPERTENSION; INFANT; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION SYSTEM; MEDICAL RECORD; MONOTHERAPY; PATIENT COMPLIANCE; PHARMACY; PRESCRIPTION; PRIORITY JOURNAL;

ADOLESCENT; ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; AGED, 80 AND OVER; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; CALCIUM CHANNEL BLOCKERS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; CHOLINESTERASE INHIBITORS; DATABASES, FACTUAL; FEMALE; HUMANS; HYPERTENSION; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; NETHERLANDS; PATIENT COMPLIANCE; PHARMACIES;

EID: 33748374207     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.1239     Document Type: Article

References (28)

1. Lenfant C, Chobanian AV, Jones DW, Roccella EJ. Seventh report of the Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7): resetting the hypertension sails. Hypertension 2003; 41(6): 1178-1179.
2. Psaty BM, Lumley T, Furberg CD, et al. Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis. JAMA 2003; 289(19): 2534-2544.
3. Cardinal H, Monfared AA, Dorais M, LeLorier J. A comparison between persistence to therapy in ALLHAT and in everyday clinical practice: a generalizability issue. Can J Cardiol 2004; 20(4): 417-421.
4. Ambrosioni E. Pharmacoeconomic challenges in disease management of hypertension. J Hypertens Suppl 2001; 19 ( Suppl 3): S33-S40.
5. Bloom BS. Continuation of initial antihypertensive medication after 1 year of therapy. Clin Ther 1998; 20(4): 671-681.
6. Caro JJ, Salas M, Speckman JL, Raggio G, Jackson JD. Persistence with treatment for hypertension in actual practice. Cmaj 1999; 160(1): 31-37.
7. Caro JJ, Speckman JL, Salas M, Raggio G, Jackson JD. Effect of initial drug choice on persistence with antihypertensive therapy: the importance of actual practice data. Cmaj 1999; 160(1): 41-46.
8. Conlin PR, Gerth WC, Fox J, Roehm JB, Boccuzzi SJ. Four-year persistence patterns among patients initiating therapy with the angiotensin II receptor antagonist losartan versus other artihypertensive drug classes. Clin Ther 2001; 23(12): 1999-2010.
9. Degli Esposti E, Sturani A, Di Martino M, et al. Long-term persistence with antihypertensive drugs in new patients. J Hum Hypertens 2002; 16(6): 439-444.
10. Esposti LD, Di Martino M, Saragoni S, et al. Pharmacoeconomics of antihypertensive drug treatment: an analysis of how long patients remain on various antihypertensive therapies. J Clin Hypertens (Greenwich) 2004; 6(2): 76-84.
11. Hasford J, Mimran A, Simons WR. A population-based European cohort study of persistence in newly diagnosed hypertensive patients. J Hum Hypertens 2002; 16(8): 569-575.
12. Marentette MA, Gerth WC, Billings DK, Zarnke KB. Anti-hypertensive persistence and drug class. Can J Cardiol 2002; 18(6): 649-656.
13. Wogen J, Kreilick CA, Livornese RC, Yokoyama K, Frech F. Patient adherence with amlodipine, lisinopril, or valsartan therapy in a usual-care setting. J Manag Care Pharm 2003; 9(5): 424-429.
14. Monane M, Bohn RL, Gurwitz JH, Glynn RJ, Levin R, Avorn J. The effects of initial drug choice and comorbidity on antihypertensive therapy compliance: results from a population-based study in the elderly. Am J Hypertens 1997; 10(7 Pt 1): 697-704.
15. Herings RMC. PHARMO: a record linkage system for post-marketing surveillance of prescription drugs in The Netherlands. Utrecht University: Utrecht, 1993.
16. Moser M. World Health Organization-International Society of Hypertension Guidelines for the management of hypertension-do these differ from the U.S. Recommendations? Which guidelines should the practicing physician follow? J Clin Hypertens (Greenwich) 1999; 1(1): 48-54.
17. WHO. Guidelines for ATC classification and DDD assignment, WHO Collaborating Centre for Drug Statistics Methodology - Nordic Council on Medicines, Oslo. In; 1999.
18. Van Wijk BLG, Klungel OH, Heerdink ER, de Boer A. Comparison of different methods to calculate refill persistence of drug use by using pharmacy records. Pharmacoepidem Drug Saf 2004; 13(S1): 44.
19. Robins JM, Gail MH, Lubin JH. More on "Biased selection of controls for case-control analyses of cohort studies". Biometrics 1986; 42(2): 293-299.
20. Jones JK, Gorkin L, Lian JF, Staffa JA, Fletcher AP. Discontinuation of and changes in treatment after start of new courses of antihypertensive drugs: a study of a United Kingdom population. BMJ 1995; 311(7000): 293-295.
21. Strom BL, Carson JL, Morse ML, LeRoy AA. The computerized on-line Medicaid pharmaceutical analysis and surveillance system: a new resource for postmarketing drug surveillance. Clin Pharmacol Ther 1985; 38(4): 359-364.
22. Lau HS, de Boer A, Beuning KS, Porsius A. Validation of pharmacy records in drug exposure assessment. J Clin Epidemiol 1997; 50(5): 619-625.
23. Choo PW, Rand CS, Inui TS, et al. Validation of patient reports, automated pharmacy records, and pill counts with electronic monitoring of adherence to antihypertensive therapy. Med Care 1999; 37(9): 846-857.
24. Steiner JF, Prochazka AV. The assessment of refill compliance using pharmacy records: methods, validity, and applications. J Clin Epidemiol 1997; 50(1): 105-116.
25. Haynes RB, McDonald H, Garg AX, Montague P. Interventions for helping patients to follow prescriptions for medications. Cochrane Database Syst Rev 2002; (2): CD000011.
26. Haynes RB, McDonald HP, Garg AX. Helping patients follow prescribed treatment: clinical applications. JAMA 2002; 288(22): 2880-2883.
27. McDonald HP, Garg AX, Haynes RB. Interventions to enhance patient adherence to medication prescriptions: scientific review. JAMA 2002; 288(22): 2868-2879.
28. Schroeder K, Fahey T, Ebrahim S. Interventions for improving adherence to treatment in patients with high blood pressure in ambulatory settings. Cochrane Database Syst Rev 2004; (2): CD004804.